Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBO-DN: Duloxetine and Pregabalin in Diabetic Neuropathy
NCT01089556Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of duloxetine, pregabalin in diabetic peripheral neuropathy (DPN), sponsored by Eli Lilly and Company. Started Mar 2010; status: completed.
02
Drugs
duloxetinepregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01089556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01089556.